US-based technology startup Arbital Health has finalised the acquisition of Santa Barbara Actuaries (SBA), an actuarial and healthcare consulting firm. 

This move is complemented by a $10m Series A financing round, led by Transformation Capital, with participation from Shaper Capital and Healthy Ventures, along with individual data and healthcare experts. 

SBA specialises in designing and measuring value-based programmes and will add resources to Arbital Health, including an actuarial team and established clients in the value-based care landscape.  

Arbital Health plans to leverage technology to assist businesses in designing and evaluating outcome-based contracts while serving as an impartial third-party adjudicator. 

Its initial product offerings include value assessments for health vendors, actuarial advisory services, and value analysis for payers, including employers and health plans.

The company's leadership team and advisory board include former FDA and VA leaders, healthcare business experts, and value-based care specialists. 

The recent funding is expected to support Arbital Health in further developing its technology and expanding its services.  

Drs Ian Duncan and Scott Rosen will be part of Arbitral Health's board, with Dr Ian Duncan also taking on the role of chief actuary for the company. 

The company aims to become a neutral adjudicator for outcomes-based contracts, aiding the healthcare sector's transition to value-based care. 

“We are very excited to welcome the Santa Barbara Actuaries team to Arbital Health," said Arbital Health president and CEO Brian M Overstreet. 

“SBA has established itself as a leading solutions provider for the entire value-based care ecosystem.  

“Their stellar reputation for impartial analysis, statistical rigour, and best-in-class services and solutions are a key element to our mission to become the neutral, third-party utility for the design, measurement, and adjudication of outcome-based contracts in US healthcare."

Overstreet added: “I am also pleased to welcome Transformation Capital as the lead investor in our $10m Series A financing.  

“Solving the misalignment of incentives in healthcare is one of the most important challenges of our era, and we are thrilled to have assembled an incredible set of investors, advisers, and team for the journey ahead.”